Health Condition 1: null- Healthy parturients aged 18-35 years with term pregnancy with single live fetus at spontaneous onset of labour, cervical dilatation of 3-5cms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. single live fetus with vertex presentation. 2. spontaneous onset of labour. 3. cervical dilatation of 3-5cms. 4. normal fetal cardiotocograph.
Exclusion criteria
Exclusion criteria: 1. contraindications to regional analgesia. 2. use of any other analgesia before recruitment to the study. 3. induction of labour with oxytocin or prostaglandins. 4. pre-labour rupture of membranes. 5. previous scarred uterus (previous caesarean section or myomectomy). 6. maternal medical disorders like • diabetes mellitus (DM) • gestational DM on insulin • severe hypertension (BP >=160/110) • pre-eclampsia • severe anaemia (Hb • valvular heart disease. 7. severe fetal growth restriction (estimated fetal weight 8. any known allergy to local anaesthetics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| an increase of 10 mm Hg or more in basal uterine tone following administration of study drugTimepoint: 20 mins | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Episodes of suspicious or pathological CTG until 30 minutes following analgesia. 2.Time to onset of satisfactory analgesia. (VAS3) 3.Incidence of hypotension/total dose of phenylephrine used. 4.Incidence of nausea/ vomiting/ pruritis. Nausea/ vomiting/ pruritis 5. Incidence of motor block 6. Postdural puncture headache Timepoint: 20 min | — |
Countries
India
Contacts
POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH